Table 2 |
||||||
|
Demographic and clinical characteristics of the study cohort |
||||||
|
entire study cohort |
entire study cohort n = 204 |
valid data on sex n = 173 |
||||
|
unknown sex n = 31 |
valid data on sex n = 173 |
men n = 88 |
women n = 85 |
|||
|
|
||||||
|
age (median age [years], IQR) |
56, 50 to 60 |
51, 48 to 60 |
56, 50 to 60 |
56, 51 to 60 |
56, 49 to 60 |
|
|
P = 0.531 |
P = 0.584 |
|||||
|
clinical diagnosis |
osteoarthritis |
107 |
5 |
102 |
54 |
48 |
|
avascular necrosis of femoral head |
10 |
0 |
10 |
8 |
2 |
|
|
rheumatoid arthritis |
7 |
0 |
7 |
3 |
4 |
|
|
arthritis secondary to trauma |
7 |
0 |
7 |
3 |
4 |
|
|
developmental hip dysplasia |
17 |
1 |
16 |
6 |
10 |
|
|
P = 0.867 |
P = 0.288 |
|||||
|
THRA design |
ASR™ |
143 |
18 |
125 |
66 |
59 |
|
DUROM® |
16 |
1 |
15 |
8 |
7 |
|
|
Cormet™ |
20 |
6 |
14 |
6 |
8 |
|
|
BHR™ |
14 |
4 |
10 |
4 |
6 |
|
|
ReCAP® |
11 |
2 |
9 |
4 |
5 |
|
|
P = 0.127 |
P = 0.877 |
|||||
|
duration of implantation (median in situ time [days], IQR) |
147, 51 to 399 |
127, 25 to 570 |
147, 55 to 384 |
124, 54 to 327 |
182, 55 to 445 |
|
|
P = 0.724 |
P = 0.373 |
|||||
|
size of the femoral component (median diameter [mm], IQR) |
46, 44 to 50 |
46, 44 to 50 |
46, 42 to 48 |
50, 48 to 52 |
44, 42 to 46 |
|
|
P = 0.175 |
P = 0.000 |
|||||
|
|
||||||
|
Hinsch et al. BMC Medicine 2011 9:113 doi:10.1186/1741-7015-9-113 |
||||||
